明年起恢复对避孕药品和用具征收增值税，原因何在

Core Viewpoint - The upcoming implementation of the VAT law on January 1, 2026, will remove the exemption for contraceptive drugs and devices, leading to a 13% VAT rate that will ultimately be borne by consumers [1][2]. Group 1: Tax Policy Changes - The VAT law will officially take effect on January 1, 2026, and will no longer include contraceptive drugs and devices in the exempt category [1]. - The removal of the exemption aligns with China's current population policy, which encourages childbirth, thus necessitating a change in tax treatment for contraceptive products [2]. Group 2: Historical Context - Contraceptive drugs and devices were exempt from VAT since the provisional regulations were first published in 1993, aimed at reducing costs associated with family planning [1]. - The shift in tax policy reflects a broader change in China's demographic strategy, moving from population control to encouraging higher birth rates [2]. Group 3: Financial Implications - The VAT is the largest tax category in China, with the Ministry of Finance reporting a VAT revenue of 58.858 billion yuan in the first ten months of the year, representing a 4% year-on-year increase [3].